Steven Cohen's position in Cytokinetics is currently worth $59.7 Million. That's 0.16% of their equity portfolio (169th largest holding). The investor owns 1.44% of the outstanding Cytokinetics stock. The first Cytokinetics trade was made in Q2 2019. Since then Steven Cohen bought shares eighteen more times and sold shares on sixteen occasions. The investor's estimated purchase price is $84.4 Million, resulting in a loss of 29%.